First Manhattan’s VivoSim Labs VIVS Stock Holding History

First Manhattan’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2	Closed	-$35	–	1726
2022 Q4	$35	Hold	2	–	–	﹤0.01%	1662
2022 Q3	$0	Hold	2	–	–	﹤0.01%	1673
2022 Q2	$0	Hold	2	–	–	﹤0.01%	1685
2022 Q1	$0	Hold	2	–	–	﹤0.01%	1704
2021 Q4	$0	Hold	2	–	–	﹤0.01%	1701
2021 Q3	$0	Hold	2	–	–	﹤0.01%	1705
2021 Q2	$0	Hold	2	–	–	﹤0.01%	1638
2021 Q1	$0	Hold	2	–	–	﹤0.01%	1575
2020 Q4	$0	Hold	2	–	–	﹤0.01%	1425
2020 Q3	$0	Hold	2	–	–	﹤0.01%	1477
2020 Q2	$0	Buy	+2	New	+$244	﹤0.01%	1488

Other funds holding VIVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

First Manhattan's VIVS Position: Q1 2023 in Review

First Manhattan sold out of VivoSim Labs (VIVS) in Q1 2023, closing a stake of 2 shares — an estimated $35 sold.

First Manhattan first reported a position in VIVS in Q2 2020 and held it in 11 quarters. The position peaked at $35 in Q4 2022. 35 funds tracked by Wall St. Rank hold VIVS as of Q1 2023.

First Manhattan reported no remaining VivoSim Labs position as of Q1 2023 after selling out during the quarter.
First Manhattan sold 2 VivoSim Labs shares in Q1 2023, an estimated $35.
First Manhattan first reported a position in VivoSim Labs in Q2 2020 and held it in 11 quarters.
First Manhattan's VivoSim Labs position peaked at $35 in Q4 2022.
35 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2023.

Based on First Manhattan's 13F filing for Q1 2023, filed 15 May 2023.